1 vement in short-term knowledge after the ACR
seminar.
2 sts to assess knowledge before and after the
seminar.
3 ad training in breast imaging before the ACR
seminar.
4 Hodgkin lymphoma, which is the topic of this
Seminar.
5 vitiligo will be emphasised throughout this
Seminar.
6 is is a large topic beyond the scope of this
Seminar.
7 inders for 1 year; and (5) a case discussion
seminar.
8 was interest in an ongoing series of virtual
seminars.
9 tandard information plus: (1) an educational
seminar; (
2) educational materials; (3) a list of availa
10 l courses but was heavily involved in making
seminars a vital part of instruction, in teaching langua
11 This Seminar adds to the previous Lancet
Seminar about eating disorders, published in 2003, with
12 This
seminar addresses only the musculoskeletal issues associ
13 This
Seminar adds to the previous Lancet Seminar about eating
14 This
Seminar aims to provide a thorough overview of these uni
15 This
Seminar aims to provide insights into the current clinic
16 We developed a course that combines
seminar and independent research elements to support stu
17 nd the literature and through osmosis during
seminars and scientific meetings.
18 lude use of joint grand rounds, patient care
seminars,
and interprofessional dialogues.
19 ducational intervention consisted of a 1-day
seminar co-taught by a Tanzanian pastor and a Tanzanian
20 ling" in the form of an outreach educational
seminar combined with implementation of on-site sigmoido
21 An outreach educational
seminar combined with implementation of on-site sigmoido
22 This
Seminar covers the basics, from terminology to aspects o
23 This
Seminar describes embryological developmental processes,
24 This
Seminar describes the clinical manifestations of androge
25 This
Seminar describes the epidemiology, lifecycles, pathophy
26 This
Seminar discusses current progress in epidemiology, path
27 This
seminar discusses the important topics of the pathophysi
28 This
Seminar draws attention to advances in the epidemiology,
29 somnia (CBT-I), tai chi chih (TCC), or sleep
seminar education active control condition for 2-hour se
30 As compared with sleep
seminar education active control condition, CBT-I reduce
31 This
Seminar focuses on changes in their epidemiology, the cu
32 This
Seminar focuses on recent advances in our understanding
33 This
Seminar focuses on the diagnosis, complications, and man
34 This
Seminar focuses on the subset of diseases called retinit
35 This
seminar focuses on these changing views and offers a new
36 This
seminar focuses on three common presentations of vertigo
37 are staff in the intervention homes attended
seminars from the hospital outreach team and received we
38 In this
Seminar I present data on the management of children wit
39 The 2016 Beaune
Seminar in Transplant research brought together research
40 ogy and antibody generation, the 2015 Beaune
Seminar in Transplant Research challenged the convention
41 The 2014 Beaune
Seminar in Transplant Research discussed the evidence fo
42 Congress and the 12th International Tinnitus
Seminar in Warsaw, Poland, provided an opportunity to re
43 n , as well as in has been covered in recent
Seminars in The Lancet.
44 ies, didactics in seven, group work in four,
seminars in three, self-directed learning in three and s
45 The
seminar included 5 topics discussed over a 4-d period.
46 This
seminar includes issues of definition and frequency of e
47 pletion of a specific communication training
seminar increased odds of consent by 1.533 (95% CI, 1.25
48 ased American Academy of Neurology-sponsored
seminar led by local opinion leaders, and follow-up mail
49 This
Seminar looks at the changing epidemiology of this aller
50 011, researchers met for the second Batsheva
Seminar on Integrative Perspectives on the Development o
51 In the decade since the last Lancet
Seminar on lung cancer there have been advances in many
52 We focus this
seminar on these changing views, and offer a new perspec
53 This
Seminar presents the most recent information about the c
54 This
Seminar provides an overview and update on management of
55 This
Seminar provides an update on epidemiology, pathogenesis
56 This
seminar reviews important features and management issues
57 This
seminar reviews the aetiology, clinical presentation, ap
58 This
Seminar reviews the changing epidemiology of invasive my
59 This
seminar reviews the effects of genes, stage of developme
60 This
Seminar reviews the epidemiology, genetics, pathophysiol
61 This
Seminar summarises the presentation, pathophysiology, di
62 In January 1999, a virtual
seminar that focused on nutrition education in medical s
63 In this
Seminar,
three types of infection will be covered: tinea
64 The
seminar,
titled "Making Room for Nutrition Education, wa
65 esearch are rapidly evolving, we aim in this
Seminar to provide an up-to-date discussion on select to
66 dit reports direct educational workshops and
seminars to address these issues.
67 In this
Seminar,
together with diagnosis, management, and treatm
68 As part of MeDALL, a scientific
seminar was held on January 24, 2011, to review current
69 In this
Seminar we critically appraise the management of Hodgkin
70 In this
Seminar we discuss advances in the understanding of the
71 In this
Seminar we discuss developments from the past 5 years in
72 In this
Seminar we discuss disease burden, recommendations for a
73 In this
Seminar we discuss important advances in the understandi
74 In this
Seminar we discuss the clinical range, diagnostic criter
75 In this
Seminar we discuss the epidemiology, pathophysiology, di
76 In this
Seminar we discuss the epidemiology, pathophysiology, di
77 ve between them, so for the purposes of this
Seminar we have adopted a transdiagnostic perspective.
78 In this
Seminar we reflect on changes in its classification crit
79 In this
Seminar we review the causes, anatomy, pathophysiology,
80 In this
Seminar we review the clinical features, diagnosis, and
81 In this
Seminar we will discuss the most common and deadly form
82 In this
Seminar,
we describe current insights into genetics and
83 In this
Seminar,
we describe recent developments in the diagnosi
84 In this
Seminar,
we discuss clinical and diagnostic approaches a
85 In this
Seminar,
we discuss clinical practice, controversies, an
86 In this
Seminar,
we discuss existing treatment for patients with
87 In this
Seminar,
we discuss pulmonary embolism and deep vein thr
88 In this
Seminar,
we discuss the clinical features, diagnosis, an
89 In this
Seminar,
we discuss the clinical presentation, epidemiol
90 In this
Seminar,
we discuss the clinical presentation, transmiss
91 In this
Seminar,
we discuss the definition, epidemiology, differ
92 In this
Seminar,
we discuss the epidemiology, causes, and sympto
93 In this
Seminar,
we discuss the main developments in Alzheimer's
94 In this
Seminar,
we examine the epidemiology of CKD worldwide, w
95 In this
Seminar,
we provide a clinically focused overview of ast
96 In this
Seminar,
we provide a comprehensive review that integrat
97 In this
Seminar,
we provide a physician-oriented overview of Cro
98 In this
Seminar,
we provide advice to clinicians on ways to mini
99 In this
Seminar,
we provide an overview of advances in the under
100 In this
Seminar,
we provide an overview of recent evidence regar
101 In this
Seminar,
we provide present results regarding rubella co
102 In this
Seminar,
we review its natural history, clinical feature
103 In this
Seminar,
we review our understanding of the risk factors
104 In this
Seminar,
we review recent data on the clinical course, t
105 In this
Seminar,
we summarise the presentation, pathophysiology,
106 This
Seminar,
which is aimed at clinicians who manage childre
107 onsored a 1-day comprehensive breast imaging
seminar,
which was attended by 2,249 radiology residents
108 This
Seminar will compare the epidemiological and clinical fe
109 This
Seminar will review the current understanding of the epi
110 rs become part of a learning culture through
seminars,
workshops, and clubs in which knowledge and pr